SVCM
BIIB icon

Saturn V Capital Management’s Biogen BIIB Stock Holding History

Saturn V Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-32,469
Closed -$8.4M – 25
2023
Q4 		$8.4M Sell
32,469
-32,207
-50% -$7.91M 3.22% 14
2023
Q3 		$16.6M Buy
64,676
+23,629
+58% +$6.32M 6.96% 5
2023
Q2 		$11.7M Buy
41,047
+3,588
+10% +$1.07M 6.48% 7
2023
Q1 		$10.4M Buy
37,459
+29,799
+389% +$8.25M 7.78% 5
2022
Q4 		$2.17M Buy
+7,660
New +$2.16M 1.8% 17

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Saturn V Capital Management's BIIB Position: Q1 2024 in Review

Saturn V Capital Management sold out of Biogen (BIIB) in Q1 2024, closing a stake of 32,469 shares — an estimated $8.4M sold.

Saturn V Capital Management first reported a position in BIIB in Q4 2022 and held it in 5 quarters. The position peaked at $16.6M in Q3 2023. 954 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Saturn V Capital Management reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • Saturn V Capital Management sold 32,469 Biogen shares in Q1 2024, an estimated $8.4M.
  • Saturn V Capital Management first reported a position in Biogen in Q4 2022 and held it in 5 quarters.
  • Saturn V Capital Management's Biogen position peaked at $16.6M in Q3 2023.
  • 954 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Saturn V Capital Management's 13F filing for Q1 2024, filed 15 May 2024.